Tarriff Scott sold EGRX
January 5, 2024 · Form 4 insider transaction
Tarriff Scott sold 4,322 shares of Eagle Pharmaceuticals, Inc. at $5.13 per share, a transaction worth $22.2K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,322
Price
$5.13
Total value
$22.2K
InsiderTarriff Scott
Role10% owner
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateJanuary 5, 2024
Filing dateJanuary 9, 2024
Shares owned after541,125
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units on January 5, 2024.